Effects of recombinant interferon-gamma on cytokine secretion from monocyte-derived macrophages infected with

Isil Fidan1, Emine Yesilyurt, Feryal Cetin Gurelik

  • 1Faculty of Medicine, Department of Medical Microbiology, Gazi University, Dekanlik Binasi 2.Kat, Beşevler, Ankara 06500, Turkey. isilfidan@yahoo.com

Insights

Recombinant interferon-gamma (rIFN-gamma) enhances protective immune responses against Salmonella typhi by modulating macrophage cytokine secretion. This suggests rIFN-gamma as a potential therapeutic target for invasive Salmonella infections.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Salmonella typhi causes typhoid fever, a significant global health concern.
  • Cytokines from macrophages are vital for host defense against Salmonella.
  • Interferon-gamma (IFN-gamma) confers protection by activating macrophages.

Purpose of the Study:

  • To investigate the impact of recombinant IFN-gamma (rIFN-gamma) on cytokine profiles of macrophages stimulated with S. typhi.
  • To assess the potential of rIFN-gamma in modulating the immune response to S. typhi infection.

Main Methods:

  • Macrophage isolation from healthy donors' blood.
  • Priming macrophages with rIFN-gamma for 72 hours.
  • Stimulation of macrophages with S. typhi and subsequent cytokine level determination via ELISA.

Main Results:

  • rIFN-gamma reversed S. typhi-induced decreases in IL-1 and IL-2 levels.
  • rIFN-gamma elevated TNF-alpha levels.
  • rIFN-gamma suppressed anti-inflammatory cytokines (IL-10, TGF-beta) elevated by S. typhi.

Conclusions:

  • rIFN-gamma promotes a protective Th1 immune response by altering cytokine secretion during S. typhi infection.
  • rIFN-gamma shows promise as a therapeutic strategy for invasive Salmonella infections.

Related Concept Videos